VELO Respiratory Test
Feb 2026
252d
Lex Diagnostics Limited
1
Total
1
Cleared
0
Denied
Lex Diagnostics Limited — FDA 510(k) Submissions
Lex Diagnostics Limited has submitted 1 FDA 510(k) premarket notifications since 2026, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Multi-target Respiratory Specimen Nucleic Acid Test Including Sars-cov-2 And Other Microbial Agents . Use the specialty filter in the sidebar to narrow results.
1 devices